Our Website is

COMING SOON

Mana`Olana Oncology is a biotechnology company breaking boundaries to identify new cancer targets and fulfill the promise of novel therapies for millions of patients with unmet medical need. We are reaching what’s elusive in the treatment of cancer.

Through a joint venture with The University of Texas MD Anderson Cancer Center, we are developing differentiated oncology therapeutics with novel targets and potentially improved safety and efficacy profiles. Our initial pipeline includes innovative antibody products, including antibody drug conjugates (ADCs), with differentiated approaches that could unleash the potential of ADCs in new ways.

Mana`Olana Oncology is initially funded by Panacea Venture.

Check back for updates on our pipeline and progress.